Two Different Approaches During Fluoroscopically Guided Interlaminar Lumbar Epidural Steroid Injection

February 3, 2015 updated by: Kenneth D Candido

Midline vs Lateral Parasagittal Approach During Fluoroscopically Guided Interlaminar Lumbar Epidural Steroid Injection: the Role of Concordant Pressure Paresthesia in Determing Outcome.

The purpose of this study is to compare two different approaches (midline and parasagittal) during interlaminar lumbar epidural steroid injection (LESI), and to verify the role of concordant pressure paresthesia occurring during the LESI in determining outcome.

The investigators are planning to include 100 patients, undergoing LESI for radicular low back pain. This will be single-blinded randomized study. Every patient will receive the same medication we would use regardless of participating in the study. The patients will be randomly assigned to one of two groups, based on the approach:

  • Group I (50 patients) - will get LESI using midline (MIL) approach.
  • Group II (50 patients) - will get LESI using parasagittal interlaminar (PIL) approach.

Study Overview

Study Type

Interventional

Enrollment (Actual)

106

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Illinois
      • Chicago, Illinois, United States, 60657
        • Chicago Anesthesia Pain Specialits

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 80 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • 18- 80 years old
  • History of low back pain and unilateral lumbosacral radiculopathy pain
  • Lumbar disk disease including disk herniations, bulging discs, and degenerated discs, where at least 50% of the disk height is preserved respective to contiguous levels

Exclusion Criteria:

  • Discogenic pain without radiculopathy pain
  • History of previous spinal surgery
  • LESI(s) in the past year
  • Allergy to methylprednisolone, or lidocaine, or iodine-based contrast
  • Concurrent use of systemic steroid medications
  • Opioid habituation
  • Pregnancy

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Midline
Midline Lumbar Epidural Steroid Injection
Active Comparator: Parasagittal
Parasagittal Lumbar Epidural Steroid Injection

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Changes in Pain Scores from baseline after Lumbar Epidural Steroid Injection
Time Frame: Days 1, 7, 14, 21, 28, 60, 120, 180, 360
Days 1, 7, 14, 21, 28, 60, 120, 180, 360
Pressure Paresthesia during injection
Time Frame: 1 day (During Lumbar Epidural Steroid Injection)
1 day (During Lumbar Epidural Steroid Injection)
Quality of life improvement change after Lumbar Epidural Steroid Injection
Time Frame: Days 1, 7, 14, 21, 28, 60, 120, 180, 360
Days 1, 7, 14, 21, 28, 60, 120, 180, 360

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

August 1, 2010

Primary Completion (Actual)

May 1, 2013

Study Completion (Actual)

May 1, 2013

Study Registration Dates

First Submitted

December 21, 2012

First Submitted That Met QC Criteria

January 3, 2013

First Posted (Estimate)

January 4, 2013

Study Record Updates

Last Update Posted (Estimate)

February 5, 2015

Last Update Submitted That Met QC Criteria

February 3, 2015

Last Verified

February 1, 2015

More Information

Terms related to this study

Other Study ID Numbers

  • Advocate-IRB-4917

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Unilateral Lumbosacral Radiculopathy Pain

Clinical Trials on Midline vs Parasagittal Lumbar Epidural Steroid Injection

Subscribe